Maxim Group Remains a Buy on Determin

By Jason Carr

In a report released today, Brian Kinstlinger from Maxim Group reiterated a Buy rating on Determin (NASDAQ: DTRM), with a price target of $6. The company’s shares closed yesterday at $3.57, close to its 52-week high of $3.79.

Kinstlinger commented:

“DTRM posted 4Q:F17 revenue of $7.5 million, which was about 10% higher than our $6.9 million estimate.”

According to TipRanks.com, Kinstlinger is a 2-star analyst with an average return of 0.1% and a 51.2% success rate. Kinstlinger covers the Technology sector, focusing on stocks such as Applied DNA Sciences, Xplore Technologies, and Tyler Technologies.

Determin has an analyst consensus of Moderate Buy, with a price target consensus of $6.

The company has a one year high of $3.79 and a one year low of $1.17. Currently, Determin has an average volume of 14.01K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Determine, Inc. operates as a global provider of SaaS enterprise contract lifecycle management, strategic sourcing, supplier management, and procure-to-pay solutions. It offers capabilities in enterprise contract lifecycle management, e-procurement, e-sourcing, spend and procurement analysis, supplier information management, invoicing, and catalog management. The company was founded in 1996 and is headquartered in Carmel, IN.